
Gilead Sciences tokenized stock pricerGILD
rGILD/USD price calculator
Live Gilead Sciences price today in USD
Do you think the price of Gilead Sciences will rise or fall today?
In-depth analysis of Gilead Sciences's market trends today
Gilead Sciences market summary
The current price of Gilead Sciences (rGILD) is $138.82, with a 24-hour change of +0.20%. The current market capitalization is approximately --, and the 24-hour trading volume is $0.00.
Gilead Sciences Key Takeaways
According to real-time chart analysis, the current technical structure for Gilead Sciences (GILD) shows a key support level at $134.40 and a primary resistance level at $140.30. A decisive move outside this range could trigger a new trending phase. Overall, the market is currently in a strongly bullish phase, with price action consolidating near recent highs following a breakout from an inverse head-and-shoulders pattern.
Technical Indicators
RSI: Currently at 62.06, indicating that market momentum is bullish and strengthening, though not yet in overbought territory (typically above 70).
MACD: The signal is Bullish (value at 1.61), with the MACD line trending above the signal line, confirming positive momentum.
MA: Strongly Bullish Structure. The price is currently trading above its 5-day ($132.83), 20-day ($132.03), 50-day ($129.48), and 200-day ($130.92) simple moving averages, signaling a robust uptrend across all timeframes.
Market Drivers
Current Gilead Sciences price and market trends are primarily influenced by the following factors:
• Robust HIV Franchise Growth: The HIV segment, led by Biktarvy and the newly launched injectable PrEP therapy Yeztugo, continues to deliver double-digit growth, with 2026 sales guidance recently raised.
• Earnings Outperformance: Despite a large one-time IPR&D charge tied to acquisitions, Gilead's Q2 underlying operational performance exceeded analyst expectations in both revenue ($7.8 billion) and adjusted EPS.
• Pipeline Momentum and AI Integration: New collaborations, such as the AI-powered tissue analytics partnership with Nucleai for antibody-drug conjugates, have renewed investor interest in Gilead's oncology growth potential.
Trading Signals
Based on the current technical structure and market momentum, the following reference trading strategies are provided:
Potential Buy Zone
• If the Gilead Sciences price approaches the $134.40 - $135.00 support zone and shows signs of stabilization, it may offer a high-probability entry point for short-term traders.
• A breakout above $140.30 accompanied by significant volume would confirm the continuation of the current bullish trend.
Risk Scenario
• If the price falls below the $132.10 mark (the recommended stop-loss level), the market may enter a short-term correction phase, potentially retesting the $130.00 psychological level.
Buy Strategy
Based on the current market structure, the following reference strategies are suggested:
Conservative Investors
• Wait for a pullback to the $134.40 support level to build a position in stages.
• Alternatively, wait for a confirmed daily close above the $140.30 resistance before entering.
Trend Investors
• If the price breaks the $140.30 resistance, follow the trend with an initial target price of $153.00.
• Further upside potential could target the $158.00 consensus analyst objective.
Long-term Investors
• As long as the price remains above the $130.90 (200-day SMA) level, the long-term bullish structure remains intact. Investors may continue to hold and accumulate on dips.
Trends Summary
Market Insights
In the short term, Gilead Sciences has exhibited a rising trend channel over the past 7 days, with market sentiment characterized as highly optimistic. The successful breakout above the $136 level has shifted the technical landscape in favor of the bulls.
Market Outlook
If Gilead Sciences successfully clears the $140.30 hurdle, the next major price target is $153.00, followed by $158.04. Conversely, if it loses the $134.40 support, the price may retreat toward $130.30.
Market Consensus
The consensus among analysts is a Moderate Buy. While short-term volatility may occur as the market absorbs recent gains, the prevailing view is that if Gilead stays above the $134.40 support, the medium-term trend will remain decidedly bullish.
Now that you understand the market, it's time to start trading. Gilead Sciences (rGILD) is actively traded on Bitget Exchange, one of the world's largest cryptocurrency platforms with over 120 million registered users. Bitget offers spot trading for rGILD/USDT with highly competitive fees, as low as 0% for makers and 0.03% for takers. The platform supports more than 1300 cryptocurrencies including Gilead Sciences, maintains a protection fund exceeding $300 million, and provides 24/7 trading with deep liquidity. Bitget consistently ranks among the top exchanges by rGILD trading volume.
Sign up for a free Bitget account and start trading now!Risk disclaimer
The above analysis is based on Bitget's real-time chart data and technical indicators, compiled and reviewed by the Bitget research team. It is for reference only and does not constitute investment advice. Cryptocurrency prices are highly volatile. Please make investment decisions based on your own risk tolerance.

GetAgent: Your AI for smarter trading decisions
Gilead Sciences market info
You can trade rGILD on Bitget
Hot stock assets trading on Bitget
Detailed introduction to Bitget rToken (rGILD)
In short, rGILD is a tokenized stock issued by licensed issuer Reality, pegged 1:1 to real Gilead Sciences stock. It supports 24/7 trading, fractional shares, and dividends, and can be used as margin for the platform's unified trading account and USDT-M futures.
Buy rGILDHow Bitget rToken (rGILD) works
During U.S. market hours—including the regular session, pre-market, after-hours, and overnight sessions—spot orders for rGILD are routed directly through a broker to the Nasdaq or NYSE order book. Once the trade is executed on the U.S. stock market, the execution result is reflected in the on-exchange spot order record. Any order you place for rGILD while the U.S. market is open will also appear on the Nasdaq or NYSE order book. This means that during U.S. market hours, the trading price and liquidity of rGILD are exactly the same as those of the underlying stock. Orders for rGILD and their execution results are part of the U.S. stock market. There is no spread or so-called de-pegging, because rGILD trades are executed directly on the U.S. stock market itself. The execution price you see for rGILD is identical to the stock's price at that exact moment.
This makes rGILD fundamentally different from traditional RWA tokens. The price of a traditional RWA asset is determined by on-chain liquidity and trading activity, whereas the price of rGILD is directly equivalent to the stock price—it does not rely on any other mechanism to peg the asset's price. In terms of trading outcomes, trading rGILD is no different from trading the stock directly.
Buy rGILD with crypto assets on Bitget for the best stock trading experience
Bitget's spot trading market has listed over 500 rTokens (including rGILD), offering native U.S. stock liquidity 24/5, with some trading pairs supporting 24/7 trading.
Market liquidity: The only tokenized stock that aligns with the market price and liquidity of major U.S. stock exchanges such as Nasdaq and the NYSE.
Maximum capital efficiency: rTokens can be used within the unified ecosystem for margin, Crypto Loans, Earn, and more, expanding the ways your assets can be used.
More flexible trading: Supports stablecoin deposits, T+0 fund turnover, 24/5 trading, with some pairs supporting 24/7 trading.
Fund security: The only RWA asset in the industry subject to daily third-party Proof of Reserves (PoR) audits, ensuring transparent asset reserves and protecting user funds.
Dividend rights: Eligible dividends are paid out to users' accounts in USDT.
Hold rGILD and enjoy corporate actions aligned with the underlying stock
Corporate actions involving rGILD (including dividend payments, stock splits, and reverse splits) are handled in the same way that a traditional broker would handle a stock position.
While holding rGILD, whenever Gilead Sciences stock pays a USD dividend, Reality automatically converts it into an equivalent amount of stablecoin (USDT) and distributes it 1:1 to the Bitget accounts of rGILD holders. As a result, holding rGILD entitles you to the same dividend rights as holding the actual stock, with the entire process handled automatically by the platform, requiring no manual action. It should be noted that dividends are subject to a flat 30% withholding tax applied by the U.S. to foreign investors. For users holding high-dividend assets (such as certain tech stocks or ETF-linked tokens), this means they can earn steady passive income on top of capital appreciation, further boosting the overall return on their holdings.
The issuer of rGILD is based in El Salvador. Therefore, the withholding tax applicable to rGILD follows the U.S. withholding tax rules for El Salvador.
Hold rGILD and enjoy the flexibility of a crypto asset
Whether you're using a traditional broker or another platform, deposits and withdrawals are rarely a seamless experience. Traditional brokers may take time to process deposits. After a stock is sold, withdrawals typically take one to two days to process, and the funds may take even longer to arrive. Securities holdings also cannot be split, transferred, or reallocated. By contrast, rGILD offers far greater flexibility than traditional stocks.
1. rGILD can be sold on the exchange, and the proceeds are immediately available for transfer, with no T+1 restriction.
2. rGILD can be freely transferred, withdrawn, or moved between sub-accounts, offering great flexibility and convenience. rGILD is essentially a regular crypto asset, with no difference in use from Bitcoin.
3. rGILD can be used directly as margin in a unified trading account to open futures positions. This allows users to participate in derivatives trading without selling their stock holdings, improving capital efficiency.
4. rGILD can be used as collateral to borrow crypto assets such as USDT, USDC, and BTC on the platform for further trading or to purchase other rToken assets. This is similar to the margin lending services offered by traditional brokers and helps improve capital efficiency.
Understanding the risks
The advantage of rGILD is that its price is exactly the same as the underlying stock's while also benefiting from the stock's deep liquidity. Even for less actively traded stocks, institutions don't need to worry about unexpected liquidations caused by price spikes resulting from insufficient on-exchange liquidity, as can happen with traditional tokens.
During weekends, when the U.S. stock market is closed, rGILD continues to function as collateral without interruption. Even though rGILD remains tradable over the weekend, its collateral value continues to be based on the last price before the U.S. market closes on Friday. This fixed index price is used for risk calculations, helping maintain a relatively stable collateral value and liquidation risk profile.
Why choose Bitget rToken? What are the main advantages of Bitget rToken over traditional stock investing?
Buy rGILD nowWhere is the best place to buy crypto like Gilead Sciences (rGILD)?
Gilead Sciences Price history (USD)
What is the highest price of Gilead Sciences?
What is the lowest price of Gilead Sciences?
Gilead Sciences price prediction
What will the price of rGILD be in 2027?
In 2027, based on a +5% annual growth rate forecast, the price of Gilead Sciences(rGILD) is expected to reach $148.61; based on the predicted price for this year, the cumulative return on investment of investing and holding Gilead Sciences until the end of 2027 will reach +5%. For more details, check out the Gilead Sciences price predictions for 2026, 2027, 2030-2050.What will the price of rGILD be in 2030?
Hot promotions
Global Gilead Sciences prices
How to buy Gilead Sciences(rGILD)

Create Your Free Bitget Account

Verify Your Account
